We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

490 hedge funds and large institutions have $11.5B invested in Bio-Rad Laboratories Class A in 2020 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 177 increasing their positions, 176 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

33% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 57

16% more capital invested

Capital invested by funds: $9.85B → $11.5B (+$1.61B)

3% more funds holding

Funds holding: 478 → 490 (+12)

1.14% more ownership

Funds ownership: 78.38% → 79.52% (+1.1%)

1% more repeat investments, than reductions

Existing positions increased: 177 | Existing positions reduced: 176

8% less call options, than puts

Call options by funds: $14.7M | Put options by funds: $16M

Holders
490
Holders Change
+12
Holders Change %
+2.51%
% of All Funds
8.67%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
76
Increased
177
Reduced
176
Closed
57
Calls
$14.7M
Puts
$16M
Net Calls
-$1.25M
Net Calls Change
+$4.17M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$164M
2
BlackRock
BlackRock
New York
+$154M
3
HM
HealthCor Management
New York
+$79.8M
4
California Public Employees Retirement System
California Public Employees Retirement System
California
+$72.4M
5
UBS AM
UBS AM
Illinois
+$66.9M

Top Sellers

1
GQG Partners
GQG Partners
Florida
-$183M
2
American Century Companies
American Century Companies
Missouri
-$102M
3
ACM
Atlanta Capital Management
Georgia
-$89.1M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$48.1M
5
Wells Fargo
Wells Fargo
California
-$42.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
FLAM
351
First Light Asset Management
Minnesota
$319K – – –
PP
352
Patron Partners
Texas
$317K +$310K +544 New
S
353
SignatureFD
Georgia
$305K +$19.4K +34 +7%
SI
354
Stephens Inc
Arkansas
$300K -$30.8K -54 -9%
AA
355
ALPS Advisors
Colorado
$297K -$5.7K -10 -2%
PA
356
Profund Advisors
Maryland
$294K +$9.11K +16 +3%
GIA
357
Gateway Investment Advisers
Ohio
$289K -$12K -21 -4%
SWA
358
SFMG Wealth Advisors
Texas
$288K +$281K +494 New
Cetera Investment Advisers
359
Cetera Investment Advisers
Illinois
$285K +$278K +489 New
RIM
360
Redpoint Investment Management
Australia
$285K +$278K +489 New
BBVA
361
Banco Bilbao Vizcaya Argentaria
Spain
$273K +$36.4K +64 +16%
WAM
362
World Asset Management
Michigan
$265K -$570 -1 -0.2%
CG
363
Colony Group
Massachusetts
$262K +$256K +449 New
FB
364
Fulton Bank
Pennsylvania
$261K +$15.9K +28 +7%
CAG
365
Csenge Advisory Group
Florida
$256K -$19.4K -34 -7%
WCFA
366
Walkner Condon Financial Advisors
Wisconsin
$250K +$2.85K +5 +1%
BC
367
Brio Consultants
California
$246K +$240K +422 New
MC
368
Maverick Capital
Texas
$243K +$237K +416 New
CAM
369
Cresset Asset Management
Illinois
$243K +$237K +417 New
Tudor Investment Corp
370
Tudor Investment Corp
Connecticut
$237K -$2.87M -5,033 -93%
PCG
371
Private Capital Group
Connecticut
$233K +$18.8K +33 +9%
MG
372
Mather Group
Illinois
$229K +$1.71K +3 +0.8%
EAMA
373
EFG Asset Management (Americas)
Florida
$226K -$1.71K -3 -0.8%
GT
374
Greenleaf Trust
Michigan
$225K +$220K +386 New
BFEC
375
Benjamin F. Edwards & Company
Missouri
$222K – – –
13 14
15
16 17

BIO Hedge Fund Activity: Q4 2020 in Review

490 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2020, worth a combined $11.5B — up 16% from $9.85B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new BIO positions and 57 closed out — a net gain of 19 holders — while 177 added to existing stakes and 176 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $164M. The largest seller was GQG Partners, exiting entirely with an estimated $183M sold.

  • 490 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2020, up from 478 in Q3 2020.
  • Funds reported $11.5B of Bio-Rad Laboratories Class A stock for Q4 2020, up 16% quarter-over-quarter.
  • 76 funds opened new Bio-Rad Laboratories Class A positions in Q4 2020 and 57 closed out, a net change of +19 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q4 2020 was Fidelity Investments, an estimated $164M added.
  • The largest Bio-Rad Laboratories Class A seller in Q4 2020 was GQG Partners, an estimated $183M sold.

Based on aggregated 13F filings for Q4 2020.